Sean Patrick Flahaven stands near the center of a theatrical empire that now controls or administers some of the most commercially valuable musical and dramatic properties in the English-speaking theater. Concord Theatricals combines the Andrew Lloyd Webber Collection, Rodgers & Hammerstein, Tams-Witmark, Samuel French, and additional major imprints under one corporate roof, giving it enormous influence over what gets licensed, marketed, revived, recorded, and promoted.

Sean Patrick Flahaven is a part-time CEO of Concord Theatricals, a freelance recording producer, a Broadway touring musical and play producer, and a part-time NYU Professor.

That scale is exactly why the internal hierarchy matters. In theory, a catalog this large should function as a broad showcase for generations of playwrights, composers, and lyricists. In practice, the question is whether certain names and brands rise to the top while others, though historically central to American theater, are pushed deeper into the corporate basement.

The power center

The timeline is important. Concord launched The Musical Company with Andrew Lloyd Webber’s Really Useful Group in 2016, and Sean Patrick Flahaven served as that venture’s founding worldwide CEO before becoming the executive leader of Concord Theatricals when the larger entity was formed in 2018. That means the executive who helped bring a premier Andrew Lloyd Webber relationship into Concord later became one of the key figures running the far larger licensing machine.

That is where the conflict question becomes more than abstract. When the same executive is tied to corporate expansion, premium musical catalogs, and active producing work, the optics are not neutral. They suggest a system in which institutional power, brand emphasis, and personal influence may converge.

Class-Action Threat: Authors and Estates vs. Concord, BMG, and Sean Patrick Flahaven

If organized as a class action, the potential plaintiff class could include thousands of authors, estates, and rights holders whose plays and musicals are licensed through Concord Theatricals, alleging that structural conflicts of interest—amplified by Sean Patrick Flahaven’s dual roles as chief theatricals executive for Concord and active first-class producer—systematically disadvantaged them in pricing, access, and opportunity. Under U.S. federal Rule 23, such a suit would need to show that the class is so numerous that joining all members is impracticable, that there are common questions of law or fact (for example, whether Concord’s and BMG’s licensing practices and affiliated production activities, overseen in part by executives like Flahaven, created anticompetitive effects), and that the named plaintiffs’ claims are typical and adequate to represent the whole group.

A certified class could potentially be brought in multiple U.S. jurisdictions, including Los Angeles, where BMG maintains major offices, depending on where licensing agreements were negotiated, administered, or where alleged harms were felt. While certification would turn on detailed legal tests—such as commonality, typicality, adequacy, and whether common issues predominate over individual ones—framing the dispute as a class-wide licensing and conflict-of-interest issue could increase pressure on Concord, BMG, and individual executives like Sean Patrick Flahaven to address claims spanning a broad swath of the theatrical catalog.

The Ragtime Test: When Concord’s Chief Theatricals Executive Produces Outside the Concord Licensing Catalog

Flahaven, Freeland Recoding Producer, Concord Theatrical Recordings, reviews average 3 Stars ratings. 

Ragtime brings the broader conflict question into unusually sharp focus. The musical is licensed by Music Theatre International, not Concord Theatricals, yet the 2025 Broadway revival cast album was released by Concord Theatricals Recordings and produced by Sean Patrick Flahaven, Concord’s Chief Theatricals Executive, alongside lyricist Lynn Ahrens and composer Stephen Flaherty. Flahaven’s own professional biographies describe him simultaneously as Concord’s senior theatrical executive and as an active album and show producer, while Concord says its theatrical services extend across licensing, script publishing, music publishing, recording, and producing. That arrangement is not evidence of illegality or misconduct: cast-album projects routinely bring together rights holders, authors, producers, labels, and outside licensors. But it creates a reasonable appearance-of-conflict question when the leader of a company representing a massive library of plays and musicals is also personally producing an album for a major musical licensed by a rival company.

The question becomes more pointed when viewed against Concord Theatricals Recordings’ own commercial operation. Concord markets and sells a substantial slate of theater albums in physical and digital formats, and the attached images show Ragtime displayed among its releases alongside titles connected to other Concord theatrical activity. Your separate review survey found an average rating of approximately three stars across the sampled Concord Theatricals Recordings releases, including a three-star assessment of Ragtime; that is editorial analysis, not a measure of sales, artistic significance, or commercial success. Still, the governance question remains: what policies separate Flahaven’s personal producing work from his leadership responsibilities over Concord’s licensing, publishing, recording, and producing businesses? Until Concord publicly explains those safeguards, the optics invite scrutiny — not because a producer may not hold an executive job, but because this particular executive oversees a corporate platform with extraordinary influence over the theatrical marketplace.

Ragtime Party Time for Flahaven

The names buried below the banner

The tension becomes sharper when one looks beyond Andrew Lloyd Webber and Rodgers & Hammerstein. Concord’s own acquisition materials for Samuel French pointed to a powerhouse roster of playwrights that includes Tennessee Williams, Arthur Miller, Neil Simon, Lorraine Hansberry, August Wilson, Tom Stoppard, Edward Albee, and David Mamet. Those are not marginal writers. They are among the defining names of modern drama, the writers who built the canon taught in classrooms, revived on Broadway, and licensed across the United States and abroad.

 Concord Theatricals celebrating the famous composers, lyricists, and playwrights, they are victims of his Misandry Marketing Department. Or was it anti-semitism? 

The same pattern appears on the musical side through Tams-Witmark and related legacy holdings. Once Andrew Lloyd Webber and Rodgers & Hammerstein are set aside, the broader field still includes giants such as Kander & Ebb, Jerry Herman, Stephen Schwartz, Irving Berlin, Cole Porter, Jerome Kern, and Marvin Hamlisch, names that helped define the commercial and artistic history of American musical theater. Yet the complaint is not that these writers vanished from the catalog. It is that their cultural and commercial weight is not matched by equal visibility in Concord’s promotional identity.

That is a powerful journalistic angle because it shifts the issue from mere ownership to editorial emphasis. A company can own or represent historic writers while still directing the brightest spotlight elsewhere.

Sean Patrick Flahaven’s Producer Credits Raise the Concord Conflict Question

Flahaven, producer of the Sound of Music national tour backed by BMG Concord Theatricals, puts its short-shift policies for the thousands of plays and musicals it represents at the top of its list when it comes to conflicts of interest!

The prodution list attributed to Concord Theatricals places Sean Patrick Flahaven in a striking dual position: he is Concord’s Chief Theatricals Executive while also carrying producer or co-producer credits connected to major Broadway titles, including Hadestown, Company, Stereophonic, Into the Woods, Some Like It Hot, The Wiz, Our Town, Ohio State Murders, and Death of a Salesman. His public biography identifies him as both a senior Concord executive and an active producer of shows and recordings, while Concord’s theatrical operation spans licensing, publishing, recording, and producing. This does not demonstrate kickbacks, improper payments, or unlawful conduct, and no article should make that accusation without direct evidence such as contracts, payment records, disclosures, or corroborated testimony. It does, however, create a legitimate governance question: what policies ensure that an executive with individual producing interests is walled off from decisions affecting the company’s licensing, publishing, marketing, recording, and production priorities?

Flahaven part-Time producer and Part-time CEO in action.

Jeffrey Richards illustrates why that question deserves attention, though public credits do not show him as a producer on most of Concord’s listed productions. His work overlaps with the Concord-produced list on Our Town and Ohio State Murders, and he also produced Purlie Victorious and The Sound Inside, titles later represented in Concord’s theatrical licensing catalog. That is normal business in Broadway’s interconnected producing community, not proof of an improper relationship. But when a producer’s Broadway work can move into the licensing system of a dominant company led by another active producer, the question becomes unavoidable: are authors, estates, investors, and independent producers receiving transparent, arm’s-length treatment, or is an increasingly small circle controlling the route from Broadway opening to long-term licensing and catalog revenue?

Tams-Witmark after the takeover

Tams-Witmark was once a major musical-theater brand in its own right, associated with classic Broadway composers and long-running licensing staples. After its incorporation into Concord Theatricals, it became part of a much larger corporate system dominated by the headline value of Andrew Lloyd Webber, Rodgers & Hammerstein, and Concord’s broader production ambitions.

If Concord’s most aggressive branding energy goes toward premium house banners, current production activity, and a handful of marquee catalogs, then the remaining legacy writers may look less like living assets and more like inherited inventory. For estates, schools, regional theaters, and producers, that matters, because visibility often shapes which titles get rediscovered and which titles drift into neglect.

The playwright’s problem

The same argument applies to the Samuel French side of the business. Concord publicly celebrated the Samuel French acquisition by invoking the stature of playwrights such as August Wilson, Arthur Miller, Tennessee Williams, Lorraine Hansberry, Neil Simon, Tom Stoppard, Edward Albee, and David Mamet. But the deeper question is how much those writers are actually foregrounded within the larger Concord ecosystem once the acquisition press release fades and the day-to-day branding takes over.

This is not a trivial complaint. Samuel French was once synonymous with the play itself: the acting edition, the backlist, the classroom, the competition script, the community theater shelf, the regional revival. When such a historic dramatic brand is absorbed into a conglomerated theatrical company whose public face leans heavily toward blockbuster musicals and current producing activity, some of the most important playwrights in the canon may seem curiously muted.

 Flahaven’s Misandry Concord is a theatrical 1990s-style website where male actors, young and old, can forget about appearing in hundreds of images. The Misandry marketing department won’t post them.

Life with Father is useful precisely because it is so historically loaded. Concord still lists the title on its site and identifies it as the play by Howard Lindsay, Russel Crouse, and Clarence Day, even describing it as “the greatest dramatic hit of modern times.” That public listing matters, because it means the issue is not outright disappearance.

The issue is symbolic underexposure. Life with Father remains one of the legendary commercial successes in Broadway history, yet it does not appear to hold the same visible cultural position in the modern Concord ecosystem as the company’s better-branded musical properties. If the longest-running Broadway play of its era can sit quietly in the archive while newer commercial priorities dominate the front of house, critics are justified in asking what kind of stewardship Concord is really offering its dramatic legacy.

Producing, licensing, and internal priorities

This is where Sean Patrick Flahaven’s dual role matters most. He is not simply managing a passive catalog. His public profile presents him as an active producer and executive, while Concord itself operates across licensing, publishing, recordings, and commercial production. That creates a legitimate question about internal priorities: which writers are merely represented, and which projects are actively elevated?

Flahaven’s management failed to celebrate Pride in June, the 250th Centennial in July, and dedicated the entire summer to the Misandy festival.Flahaven’s management failed to celebrate Pride in June, the 250th Centennial in July, and dedicated the entire summer to the Misandy festival.

Even without proving any improper act, the structure creates an appearance problem. A company with this much power over theater rights can shape not just access, but attention. And when the executive leadership is also tied to producing activity, the distinction between neutral stewardship and selective promotion becomes harder to see from the outside.

BMG’s German Tie, Concord’s Catalog, and the Legacy of Exile

Famous German Jewish composers, lyricists and dramatists who escaped fron the Nazis. 

Kurt Weill — The Threepenny Opera, Lady in the Dark, Lost in the Stars

Frederick Loewe — Brigadoon, Paint Your Wagon, My Fair Lady, Camelot, Gigi

Alan Jay Lerner — Brigadoon, Paint Your Wagon, My Fair Lady, Camelot, Gigi, On a Clear Day You Can See Forever

Erich Wolfgang Korngold — Die tote Stadt, The Adventures of Robin Hood, Kings Row, The Sea Hawk

Bertolt Brecht — The Threepenny Opera, Mother Courage and Her Children, The Life of Galileo, The Caucasian Chalk Circle, The Good Person of Szechwan

Ernst Toller — Man and the Masses, The Machine Wreckers, Hinkemann, Hoppla, We’re Alive!

Franz Werfel — Jacobowsky and the Colonel, The Forty Days of Musa Dagh, The Song of Bernadette, Goat Song

BMG’s $14 billion acquisition of Concord Theatricals places the German music giant in an awkward spot: it now controls a licensing powerhouse whose senior staff skews female and whose marketing leans inclusive, yet whose most valuable legacy catalog is overwhelmingly male-written—and deeply shaped by artists who fled Nazi Germany. That tension could flare if licensing choices or production mandates are perceived as ideologically driven, dragging BMG into U.S. culture-war debates it never sought. The irony is thick: Germany adores Snoopy—the “most famous dog in the world,” a staple of German children’s culture—while many of Concord’s cornerstone Broadway works were created by Jewish composers and playwrights who escaped Germany precisely because the regime that once ruled there would have banned them.

Among those exiles are Kurt Weill, whose Berlin stardom turned into Broadway reinvention with titles like Lady in the Dark and Lost in the Stars; Frederick Loewe, the Austrian-born pianist who paired with Lerner for My Fair Lady and Camelot; and Erich Wolfgang Korngold, whose Viennese opera pedigree helped define Hollywood’s golden-age sound. Playwrights and librettists such as Bertolt Brecht (whose wife Helene Weigel was Jewish), Ernst Toller, and Franz Werfel also found refuge in New York, reshaping American theater with works like The Threepenny Opera, Man and the Masses, and Jacobowsky and the Colonel. Today, Concord licenses many of these very titles, meaning BMG’s new theatrical portfolio rests on art born from persecution—art that now sits alongside a modern, more diverse catalog and a leadership team that may prioritize different values than the era that produced it.

The gender argument — and the older canon

You also raise another dimension worth incorporating: the imbalance between legacy male writers who built much of the commercial American theater and a newer corporate language that may emphasize contemporary branding priorities without giving equal historical weight to the older canon. That is a delicate point, but it can be made carefully. The issue is not whether women playwrights or newer voices should receive more attention; they should. The issue is whether Concord has built a public-facing identity that celebrates certain institutional narratives while underplaying the extraordinary commercial and historical significance of many writers whose catalogs it also controls.

That tension does not need to be framed as ideology alone. It can be framed as curatorial imbalance. A company that inherited some of the greatest commercial playwrights, librettists, composers, and lyricists in American theater history now faces the burden of showing that it values them as more than archival assets.

Snoopy, Pride, and the History Concord Leaves Offstage

Concord Theatricals’ treatment of Snoopy!!! The Musical raises a broader question about stewardship, visibility, and whose work receives institutional recognition. The company’s materials foreground the 1982 Off-Broadway version while giving far less prominence to the 1975 San Francisco world premiere and the 1976 Bicentennial engagement at Philadelphia’s Forrest Theatre—a major Shubert presentation during America’s 200th-anniversary celebrations. Critics of Concord’s approach argue that this framing also diminishes the artists behind the original production, including the largely gay creative team that helped turn Charles M. Schulz’s characters into a viable and enduring theatrical property. The concern is not that later versions should be erased, but that the history of the original production, its creators, and its landmark Philadelphia engagement should be presented honestly and prominently.

For 2026 June Pride Month, Flahaven would not honor gay creators of Peanuts musicals. 

The criticism becomes sharper in light of what the article characterizes as missed opportunities: no apparent Pride Month recognition in June for the queer creative lineage behind You’re a Good Man, Charlie Brown and Snoopy!!!, followed by no apparent July recognition of the 1976 Bicentennial Snoopy! engagement or of American-themed plays and musicals in Concord’s enormous catalog. The article further contends that Concord’s marketing team did not act on requests to recognize the musical’s 50th anniversary, restore attention to “Friend,” or add the Olivier Award-nominated London production to the show’s online history. If accurate, those omissions are not merely promotional oversights. They reinforce the larger accusation that Concord and its senior leadership have allowed a commercially valuable property to be licensed and monetized while the artists, productions, queer history, and early milestones that gave it cultural value remain pushed offstage.

SNOOPY THE MUSICAL VIDEO – 5 MINUTES PLAYTIME

The Bottom Line

Taken together, the story is larger than one executive bio or one corporate acquisition. It is about what happens when a theater giant absorbs legacy brands, centralizes power, and decides which names receive the marquee and which remain buried in the index. Andrew Lloyd Webber and Rodgers & Hammerstein are obvious crown jewels. But the same empire also carries the names of Tennessee Williams, Arthur Miller, Neil Simon, August Wilson, Tom Stoppard, Edward Albee, David Mamet, Lorraine Hansberry, Howard Lindsay, Russel Crouse, Kander & Ebb, Jerry Herman, Stephen Schwartz, Irving Berlin, Cole Porter, Jerome Kern, and Marvin Hamlisch.

That is why this article has real force. It is not merely saying Concord is large. It is saying Concord may be creating an internal class system inside its own catalog, one in which the most aggressively branded musical assets dominate the public face of the company while many of the greatest writers in American theater sit farther down the ladder, represented but not fully championed.

The Bottom Line

The Sean Patrick Flahaven story is not just about one executive biography; it is about a system. He remains the public face most closely associated with Concord Theatricals’ rise, its acquisitions, and its overlap between licensing power and producing activity, so it is fair that scrutiny lands on him first. But the larger issue is institutional: Concord has become powerful enough to decide which writers are spotlighted, which titles are buried, and which version of theatrical history the marketplace is encouraged to remember.

Editor Contact

Michael L Grace

mlgesqusa@gmail.com

Concord Theatricals Bio:

Michael l Grace.com

SOURSES;

U.S. Federal Rules of Civil Procedure, Rule 23 (Class Actions)
Variety, reporting on Concord’s acquisition of Broadway Licensing Global
Concord Theatricals, official team and leadership page
Music Business Worldwide, reporting on BMG–Concord merger and leadership
Music Business Worldwide, reporting on Concord’s Los Angeles office opening
BMG, official U.S. contact and office information
OnStage Blog, reporting on legal battle surrounding Broadway Licensing deal with Concord
HighPerformr.ai, company profile on BMG locations and headquarters
Vanderbilt Law Review, scholarship on blanket licensing and antitrust principles
Indiana Law Journal, article on music copyright associations and antitrust laws
ClassAction.org, information on class certification standards and procedures
Miller Shah LLP, overview of class action litigation in the United States
Wikipedia, entry on Concord (entertainment company) and Concord TheatricalsConcord Music, “Concord Music Announces the Acquisition of Samuel French and the Formation of Concord Theatricals: The Worldwide Theatrical Licensing, Publishing, and Producing Company,” December 16, 2018.
Playbill, “Concord Music Acquires Samuel French, Forms New Theatrical Licensing Conglomerate, Concord Theatricals,” December 16, 2018.
The New York Times, “Concord Music Acquires Samuel French in Big Push Into Theater,” December 17, 2018.
Broadway News, “Concord Music Acquires Samuel French to Form Large Theatrical Licensing Company,” December 16, 2018.
BroadwayWorld, “Concord Music Acquires Samuel French Forming Concord Theatricals,” December 17, 2018.
Music Week, “The Greatest Show Tune Catalogue: Concord Music Launch Theatrical Division Following Samuel French Acquisition,” December 17, 2018.
Music Business Worldwide, “Concord Music Buys Theatre Publisher and Licensor Samuel French, Launches Concord Theatricals,” December 16, 2018.
Concord Music, “Concord Theatricals and Andrew Lloyd Webber’s The Really Useful Group Announce Long-Term Partnership,” October 26, 2021.
Variety, “Andrew Lloyd Webber, Concord Theatricals Extend Partnership,” October 27, 2021.
Concord Music, “Concord Announces Executive Promotions in Concord Theatricals,” March 30, 2020.
Variety, “BMG Production Music, Concord Theatricals Announce Executive Appointments,” April 1, 2020.
Music Business Worldwide, “Sean Patrick Flahaven Promoted to Chief Theatricals Executive at Concord,” March 31, 2020.
Concord Theatricals, “Team.”
New York University Tisch School of the Arts, “Sean Patrick Flahaven.”
Broadway Producers Alliance, “Sean Patrick Flahaven.”
Variety500, “Sean Patrick Flahaven.”
Variety500, “Cameron Mackintosh.”
Concord Theatricals Recordings, “About.”
Dramatists Guild Foundation, “In Conversation: Sean Patrick Flahaven and Andrew Lippa,” January 8, 2020.
Concord Theatricals, “Hadestown.”
Broadway News, “A New Player Shakes Up the World of Theatrical Licensing,” September 2, 2019.
Broadway News, “Concord Theatricals Will Receive New Dramatists’ Konecky Award,” March 24, 2024.
Playbill, “Ali Roselle, Imogen Lloyd Webber, More Assume New Executive Roles at Concord Theatricals,” January 7, 2025.
Broadway News, “Concord Acquires Broadway Licensing Global and Its Family of Imprints,” May 8, 2025.
Variety, “Concord Buys Broadway Licensing Global,” May 8, 2025.
Playbill, “Concord Acquires Broadway Licensing Global and Its Family of Imprints,” May 7, 2025.
Deadline, “Concord Theatricals Acquires Major Competitor Broadway Licensing Global,” May 8, 2025.
Variety, “Sony Music Publishing and Kane Brown’s Verse 2 Renew Deal; Concord Acquires Broadway Licensing Global,” May 15, 2025.
Broadway News, “Concord Theatricals Acquires Exclusive Worldwide Licensing Rights for Hamilton,” November 18, 2025.
Broadway News, “Concord Theatricals Acquires Licensing Rights for Almost Famous Musical,” August 19, 2026.
Concord Music, “Concord Theatricals Recordings Announces Release Date for the 2025 Broadway Cast Recording of Lincoln Center Theater’s Revival of Ragtime,” November 20, 2025.
Lincoln Center Theater, “Ragtime Cast Recording Announces Release Date,” November 20, 2025.
Playbill, “Ragtime Revival Album Released January 9,” January 8, 2026.
Music Theatre International, “Ragtime, Version 1.”
Concord Theatricals, “Snoopy!!! (Original).”
Concord Theatricals, “The World According to Snoopy.”
Cruise Line History, “No Friend of Snoopy: Sony Caught in the Middle as Peanuts Worldwide and Concord Theatricals Fumble a 50th Anniversary.”
Cartoon Research, “Snoopy the Musical on Records,” December 26, 2016.
Sony Pictures Entertainment, “Completion of Acquisition of Stake in Peanuts Holdings LLC,” March 2026.
Variety, “Sony to Acquire Control of Peanuts in $457 Million Deal,” December 18, 2025.
Concord Theatricals, “Life with Father.”
Jeffrey Richards Associates, “Jeffrey Richards Associates.”
Playbill, “Jeffrey Richards.”
Wesleyan University, “Producer Jeffrey Richards ’69 Keeps Broadway Buzzing,” April 6, 2025.